Global Respiratory Syncytial Virus Diagnostics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 3813

Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, and more and more government initiatives, China, India, Japan and Malaysia are expected to become the fastest growing markets in the region.
In 2018, the global Respiratory Syncytial Virus Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Respiratory Syncytial Virus Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Syncytial Virus Diagnostics development in United States, Europe and China.

The key players covered in this study
Becton Dickinson
Abbott Laboratories
Alere
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech Group
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion

Market segment by Type, the product can be split into
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other

Market segment by Application, split into
Hospitals
Laboratory
Clinics
Homecare

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Respiratory Syncytial Virus Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Respiratory Syncytial Virus Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Respiratory Syncytial Virus Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Direct Fluorescent Antibody Method
1.4.3 Rapid Antigen Diagnostic Tests
1.4.4 Molecular Diagnostics
1.4.5 Chromatographic Immunoassay
1.4.6 Diagnostic Imaging
1.4.7 Gel Microdroplets
1.4.8 Flow Cytometry
1.4.9 Other
1.5 Market by Application
1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Laboratory
1.5.4 Clinics
1.5.5 Homecare
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Respiratory Syncytial Virus Diagnostics Market Size
2.2 Respiratory Syncytial Virus Diagnostics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Regions (2014-2025)
2.2.2 Respiratory Syncytial Virus Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Respiratory Syncytial Virus Diagnostics Market Size by Manufacturers
3.1.1 Global Respiratory Syncytial Virus Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.3 Key Players Respiratory Syncytial Virus Diagnostics Product/Solution/Service
3.4 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Type (2014-2019)
4.2 Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
5.2 Respiratory Syncytial Virus Diagnostics Key Players in United States
5.3 United States Respiratory Syncytial Virus Diagnostics Market Size by Type
5.4 United States Respiratory Syncytial Virus Diagnostics Market Size by Application

6 Europe
6.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
6.2 Respiratory Syncytial Virus Diagnostics Key Players in Europe
6.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type
6.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application

7 China
7.1 China Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
7.2 Respiratory Syncytial Virus Diagnostics Key Players in China
7.3 China Respiratory Syncytial Virus Diagnostics Market Size by Type
7.4 China Respiratory Syncytial Virus Diagnostics Market Size by Application

8 Japan
8.1 Japan Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
8.2 Respiratory Syncytial Virus Diagnostics Key Players in Japan
8.3 Japan Respiratory Syncytial Virus Diagnostics Market Size by Type
8.4 Japan Respiratory Syncytial Virus Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
9.2 Respiratory Syncytial Virus Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Type
9.4 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Application

10 India
10.1 India Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
10.2 Respiratory Syncytial Virus Diagnostics Key Players in India
10.3 India Respiratory Syncytial Virus Diagnostics Market Size by Type
10.4 India Respiratory Syncytial Virus Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
11.2 Respiratory Syncytial Virus Diagnostics Key Players in Central & South America
11.3 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Type
11.4 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Application

12 International Players Profiles
12.1 Becton Dickinson
12.1.1 Becton Dickinson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Respiratory Syncytial Virus Diagnostics Introduction
12.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.1.5 Becton Dickinson Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Respiratory Syncytial Virus Diagnostics Introduction
12.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.2.5 Abbott Laboratories Recent Development
12.3 Alere
12.3.1 Alere Company Details
12.3.2 Company Description and Business Overview
12.3.3 Respiratory Syncytial Virus Diagnostics Introduction
12.3.4 Alere Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.3.5 Alere Recent Development
12.4 Beckman Coulter/Danaher
12.4.1 Beckman Coulter/Danaher Company Details
12.4.2 Company Description and Business Overview
12.4.3 Respiratory Syncytial Virus Diagnostics Introduction
12.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.4.5 Beckman Coulter/Danaher Recent Development
12.5 Bio-Rad Laboratories
12.5.1 Bio-Rad Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Respiratory Syncytial Virus Diagnostics Introduction
12.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.5.5 Bio-Rad Laboratories Recent Development
12.6 Coris BioConcept
12.6.1 Coris BioConcept Company Details
12.6.2 Company Description and Business Overview
12.6.3 Respiratory Syncytial Virus Diagnostics Introduction
12.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.6.5 Coris BioConcept Recent Development
12.7 DiaSorin SPA
12.7.1 DiaSorin SPA Company Details
12.7.2 Company Description and Business Overview
12.7.3 Respiratory Syncytial Virus Diagnostics Introduction
12.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.7.5 DiaSorin SPA Recent Development
12.8 Eiken Chemical
12.8.1 Eiken Chemical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Respiratory Syncytial Virus Diagnostics Introduction
12.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.8.5 Eiken Chemical Recent Development
12.9 Elitech Group
12.9.1 Elitech Group Company Details
12.9.2 Company Description and Business Overview
12.9.3 Respiratory Syncytial Virus Diagnostics Introduction
12.9.4 Elitech Group Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.9.5 Elitech Group Recent Development
12.10 Fujirebio
12.10.1 Fujirebio Company Details
12.10.2 Company Description and Business Overview
12.10.3 Respiratory Syncytial Virus Diagnostics Introduction
12.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
12.10.5 Fujirebio Recent Development
12.11 Grifols
12.12 Hoffmann La Roche
12.13 Hologic
12.14 Novartis Diagnostics
12.15 Ortho Clinical Diagnostics
12.16 Roche Diagnostics
12.17 Scienion

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details